HomeProductsBioactive CompoundsCell CyclePPARAleglitazar
Chemical structure of CAS 475479-34-6

Aleglitazar

CAS No.475479-34-6
MDL No.N/A
MFC24H23NO5S
MW437.50
InChI KeyDAYKLWSKQJBGCS-NRFANRHFSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.475479-34-6
Product NameAleglitazar

Biological Targets

PPARA·PPARG

Associated Conditions

type 2 diabetes mellitus
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Effects of high dose aleglitazar on renal function in patients with type 2 diabetes.

International journal of cardiology • Vol. 151, Issue 2 • 2011
PMID: 20837369DOI: 10.1016/j.ijcard.2010.08.037

Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha.

PloS one • Vol. 5, Issue 8 • 2010
PMID: 20811644PMC: PMC2928300DOI: 10.1371/journal.pone.0012399

Pharmacokinetics, pharmacodynamics, and tolerability of aleglitazar in patients with type 2 diabetes: results from a randomized, placebo-controlled clinical study.

Clinical pharmacology and therapeutics • Vol. 88, Issue 2 • 2010
PMID: 20336066DOI: 10.1038/clpt.2009.259

Neuropathy, retinopathy, and glucose-lowering treatments.

Diabetes care • Vol. 33, Issue 6 • 2010
PMID: 20508223PMC: PMC2875466DOI: 10.2337/dc10-zb06

Documentation

Similar Products